SCHEMBL13099488

SCHEMBL13099488

CCOC(=O)CC(Br)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
TRPA1 O75762 1/20 0.46
ALOX15 P16050 3/20 0.44
GAA P10253 2/20 0.44
MGAM O43451 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
HSD17B10 Q99714 2/20 0.38
CHRM1 P11229 1/20 0.38
ADORA1 P30542 1/20 0.38
KDM4E B2RXH2 1/20 0.37
HTT P42858 1/20 0.37
F2 P00734 2/20 0.36
F10 P00742 1/20 0.36
LMNA P02545 1/20 0.36
SOAT1 P35610 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5673202 0.83 ALDH1A1 (0.50) ALDH1A1TRPA1ALOX15GAAMGAM
SCHEMBL3069909 0.81 ALDH1A1 (0.48) ALDH1A1TRPA1ALOX15GAAMGAM
SCHEMBL17841947 0.81 ALDH1A1 (0.48) ALDH1A1TRPA1ALOX15GAAMGAM
SCHEMBL19936530 0.79 ALDH1A1 (0.46) ALDH1A1TRPA1ALOX15GAAMGAM
SCHEMBL8896554 0.78 TSHR (0.40) ALDH1A1GAAMGAMSIMGAM2
SCHEMBL6585676 0.78 ALDH1A1 (0.54) ALDH1A1TRPA1ALOX15GAAMGAM
SCHEMBL2321958 0.78
SCHEMBL27830172 0.78 ALDH1A1 (0.45) ALDH1A1TRPA1ALOX15GAAMGAM
SCHEMBL11304803 0.77 ALDH1A1 (0.48) ALDH1A1TRPA1ALOX15GAAMGAM
SCHEMBL6158875 0.77 ALOX15 (0.46) ALDH1A1TRPA1ALOX15GAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267698-A1 Benzimidazole and Pyridylimidazole Derivatives NEUROGEN CORPORATION 2010-10-21 US disclosed
US-7642267-B2 Benzimidazole and pyridylimidazole derivatives NEUROGEN CORPORATION (US) 2010-01-05 US disclosed
US-20080227793-A1 Benzimidazole and Pyridylimidazole Derivatives NEUROGEN CORPORATION 2008-09-18 US disclosed
US-7300945-B2 Benzimidazole and pyridylimidazole derivatives NEUROGEN CORPORATION (US) 2007-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267698-A1 Benzimidazole and Pyridylimidazole Derivatives GABBR1, GABBR2, GABRA2 ALDH1A1 470/4885TRPA1 738/4885ALOX15 3390/4885
US-20080227793-A1 Benzimidazole and Pyridylimidazole Derivatives GABBR1, GABBR2, GABRA2 ALDH1A1 470/4885TRPA1 738/4885ALOX15 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.